PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+13.28%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$286M
AUM Growth
+$286M
(+89%)
Cap. Flow
+$99.4M
Cap. Flow
% of AUM
34.79%
Top 10 Holdings %
Top 10 Hldgs %
42.51%
Holding
111
New
29
Increased
24
Reduced
8
Closed
15
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$14M |
| 2 |
Dentsply Sirona
XRAY
|
$10.4M |
| 3 |
Boston Scientific
BSX
|
$7.18M |
| 4 |
VRAY
ViewRay, Inc.
VRAY
|
$6.8M |
| 5 |
Axogen
AXGN
|
$6.79M |
Top Sells
| 1 |
SI-BONE Inc
SIBN
|
$4.49M |
| 2 |
Amgen
AMGN
|
$3.89M |
| 3 |
Tandem Diabetes Care
TNDM
|
$3.61M |
| 4 |
Standard BioTools
LAB
|
$3.44M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.33M |
Sector Composition
| 1 | Healthcare | 89.3% |
| 2 | Industrials | 1.55% |
| 3 | Financials | 0.65% |
| 4 | Technology | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Inspire Medical Systems
INSP
$2.77B
| $20.4M | 2.89% | 358,500 -4,173 | -1% | -$237K |
|
2
ICU Medical
ICUI
$3.15B
| $17.6M | 2.51% | 73,619 +8,500 | +13% | +$2.03M |
|
|
NSTG
3
DELISTED
NanoString Technologies, Inc.
NSTG
| $15.6M | 2.22% | 651,441 +55,049 | +9% | +$1.32M |
|
|
4
Zimmer Biomet
ZBH
$21B
| $14M | 2% | +110,000 | New | +$14M |
|
|
5
Dentsply Sirona
XRAY
$2.85B
| $10.4M | 1.48% | +210,000 | New | +$10.4M |
|
6
STAAR Surgical
STAA
$1.36B
| $10.1M | 1.43% | 294,842 +96,586 | +49% | +$3.3M |
|
|
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
| $8.84M | 1.26% | 1,196,805 +920,000 | +332% | +$6.8M |
|
8
Guardant Health
GH
$8.41B
| $8.73M | 1.24% | 113,800 +3,437 | +3% | +$264K |
|
|
9
Boston Scientific
BSX
$156B
| $8.06M | 1.15% | 210,000 +186,965 | +812% | +$7.18M |
|
10
Establishment Labs
ESTA
$1.2B
| $7.73M | 1.1% | 321,725 +34,326 | +12% | +$825K |
|
11
DexCom
DXCM
$29.5B
| $7.72M | 1.1% | 64,787 -7,713 | -11% | -$919K |
|
|
12
Axogen
AXGN
$743M
| $6.79M | 0.97% | +322,500 | New | +$6.79M |
|
|
IVC
13
DELISTED
Invacare Corporation
IVC
| $6.58M | 0.94% | +786,439 | New | +$6.58M |
|
14
Gilead Sciences
GILD
$140B
| $6.5M | 0.92% | +100,000 | New | +$6.5M |
|
|
XENT
15
DELISTED
Intersect ENT, Inc
XENT
| $6.3M | 0.9% | 195,826 +5,491 | +3% | +$177K |
|
|
AGN
16
DELISTED
Allergan plc
AGN
| $6.17M | 0.88% | 42,125 +22,125 | +111% | +$3.24M |
|
17
Danaher
DHR
$147B
| $5.94M | 0.84% | +45,000 | New | +$5.94M |
|
18
Orthofix Medical
OFIX
$592M
| $5.92M | 0.84% | 105,000 +92,262 | +724% | +$5.2M |
|
19
Baxter International
BAX
$12.7B
| $5.69M | 0.81% | 70,000 +6,000 | +9% | +$488K |
|
|
20
Standard BioTools
LAB
$481M
| $5.58M | 0.79% | 420,000 -258,596 | -38% | -$3.44M |
|
21
OrthoPediatrics
KIDS
$536M
| $5.31M | 0.75% | 120,000 +3,169 | +3% | +$140K |
|
|
AMRN
22
Amarin Corp
AMRN
$311M
| $4.88M | 0.69% | 235,204 -154,276 | -40% | -$3.2M |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $4.72M | 0.67% | +50,000 | New | +$4.72M |
|
24
Masimo
MASI
$7.59B
| $4.49M | 0.64% | 32,500 +24,717 | +318% | +$3.42M |
|
|
RCM
25
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.42M | 0.63% | 457,141 +421,858 | +1,196% | +$4.08M |
|